Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Identify ideal timing for harvesting losses on dividend ETFs to optimize tax outcomes while keeping your investment strategy intact.
10,702 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When headlines shout about quantum computing stock plummeting, it can feel like a nerve-wracking moment for investors...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
The Invesco QQQM ETF offers a low-cost way to ride tech gains, but a handful of mega-caps shape most of its outcomes,...
Bloom Energy stock reached a fresh intraday high as data-center demand and green-energy tech advances grab headlines....
XRP has shed roughly 44% over the past year, prompting renewed debate about a rebound. Analysts point to regulatory c...
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
Upstart has stunned the market with a renewed focus on AI-powered lending, but questions remain. This article breaks ...
A wave of borrowing among AI builders is reshaping how investors view growth. NVIDIA, Oracle, and SpaceX are tapping ...
A San Diego startup led by a former Navy SEAL is using AI to forge a new path for defense contracting. The move draws...
In a year marked by mixed silver signals, investors are weighing two distinct paths: the cash-flow stability of SIL v...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...